07:00 , May 4, 2015 |  BioCentury  |  Emerging Company Profile

Nixing Niemann-Pick

Vtesse Inc. is hoping to change the course of disease in Niemann-Pick type C, a fatal ultra-Orphan lysosomal storage disorder, using a compound plucked from NIH's Therapeutics for Rare and Neglected Diseases repurposing project. Niemann-Pick...
07:00 , Jun 27, 2013 |  BC Innovations  |  Distillery Techniques

Technology: Imaging

This week in techniques Approach Summary Licensing status Publication and contact information Imaging Chemical reporter approach using strain-promoted alkyne-azide cycloaddition (SPAAC) to track cellular glycoproteins A chemical approach...
08:00 , Feb 5, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Metabolic disease

This week in therapeutics Indication Target/ marker/ pathway Summary Licensing status Publication and contact information Metabolic disease...